MIMBIOSIS revolutionizes the construction industry by transforming textile waste into carbon-negative panels partnering with natures ultimate technology, mycelium.
We leverage the extraordinary potential of mycelium, the fungal root system, as a groundbreaking biotechnological solution for industries using plastic foam. By cultivating mycelium with textile waste, we produce carbon-negative and biodegradable materials with exceptional acoustic and thermal insulation, flame retardancy, hydrophobicity, and impact resistance. This innovative approach not only addresses critical issues of textile waste that plague the planet but also offers the plastic reliant industries a sustainable alternative to traditional plastic foams.
MIMBIOSIS is committed to a circular future, providing sustainable alternatives that not only protect the environment but also enhance the performance and safety of various industries.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was MIMBIOSIS founded?
MIMBIOSIS was founded in 2022.
What industry is MIMBIOSIS in?
MIMBIOSIS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MIMBIOSIS based?
MIMBIOSIS is headquartered in Munich, Germany.
Find investors for your startup like MIMBIOSIS
Gritt sends AI-personalised outreach to each investor — from your Gmail
